Nabil Adra, Christof Vulsteke, Yohann Loriot, Alejo Rodriguez-Vida, Zhentao Zhang, Ja Hyeon Ku, Judit Oláh, Anna Kolodziej, Maksym Sabadash, Gunhild von Amsberg, Nimira S. Alimohamed, Peter H. O'Donnell, Oleksandr Lychkovsky, Girish S. Kulkarni, Jasmine Lichfield, Changting Meng, David Huang, Chethan Ramamurthy, Blanca Homet Moreno, Pongwut Danchaivijitr. "Neoadjuvant and adjuvant (neoadj-adj) enfortumab vedotin (EV) plus pembrolizumab (pembro) in participants with cisplatin-ineligible muscle-invasive bladder cancer (MIBC): An analysis of clinically relevant subgroups in KEYNOTE-905.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.4613